Clinical isolates of Salmonella enterica serovar agona producing NDM-1 metallo-β-lactamase: First report from Pakistan

Journal of Clinical Microbiology

Volumn 53, Issue 1, 2015, Pages 346-348

  Irfan, Seema ^a   Khan, Erum ^a   Jabeen, Kauser ^a   Bhawan, Pushpa ^a   Hopkins, Katie L ^b   Day, Martin ^b   Nasir, Amna ^a   Meunier, Daniele ^b   Woodford, Neil ^b  

^a AGA KHAN UNIVERSITY   (Pakistan)

^b PUBLIC HEALTH ENGLAND   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AZITHROMYCIN; CEFTRIAXONE; CIPROFLOXACIN; COLISTIN; FOSFOMYCIN; METALLO BETA LACTAMASE; NDM 1 METALLO BETA LACTAMASE; UNCLASSIFIED DRUG; ANTIINFECTIVE AGENT; BETA LACTAMASE; BETA-LACTAMASE NDM-1;

ABDOMINAL PAIN; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM ISOLATE; BACTERIUM ISOLATION; CASE REPORT; CHILD; DIARRHEA; FECES CULTURE; FEVER; HOSPITAL DISCHARGE; HUMAN; INFANT; INFANTILE DIARRHEA; LEUKOCYTE COUNT; MICROSCOPY; PAKISTAN; PRESCHOOL CHILD; SALMONELLA ENTERICA; VOMITING; ANTIBIOTIC RESISTANCE; DRUG EFFECTS; ENZYMOLOGY; FECES; GENETICS; MICROBIAL SENSITIVITY TEST; MICROBIOLOGY; SALMONELLA INFECTIONS;

SALMONELLA; SALMONELLA ENTERICA;

ANTI-BACTERIAL AGENTS; BETA-LACTAMASES; DRUG RESISTANCE, BACTERIAL; FECES; HUMANS; INFANT; MICROBIAL SENSITIVITY TESTS; PAKISTAN; SALMONELLA ENTERICA; SALMONELLA INFECTIONS;

EID: 84919474546     PISSN: 00951137     EISSN: 1098660X     Source Type: Journal    
DOI: 10.1128/JCM.02396-14     Document Type: Article

References (17)

1. Chen HM, Wang Y, Su LH, Chiu CH. 2013. Nontyphoid salmonella infection: microbiology, clinical features, and antimicrobial therapy. Pediatr Neonatol 3: 147-152. http://dx.doi.org/10.1016/j.pedneo.2013 .01.010.
2. Feasey NA, Dougan G, Kingsley RA, Heyderman RS, Gordon MA. 2012. Invasive nontyphoidal salmonella disease: an emerging and neglected tropical disease in Africa. Lancet 379:2489-2499. http://dx.doi.org /10.1016/S0140-6736(11)61752-2.
3. Irfan S, Ahmad A, Guhar D, Khan E, Malik F, Mahmood S, Zafar A. 2010. Fluoroquinolone and macrolide co-resistance in clinical isolates of Campylobacter species: a 15-year study in Karachi, Pakistan. East Mediterr Health J 16:1226-1230.
4. Sultan BA, Khan E, Hussain F, Nasir A, Irfan S. 2013. Effectiveness of modified Hodge test to detect NDM-1 carbapenemases: an experience from Pakistan. J Pak Med Assoc 63:955-960.
5. Su LH, Chiu CH, Chu C, Ou JT. 2004. Antimicrobial resistance in nontyphoid Salmonella serotypes: a global challenge. Clin Infect Dis 39: 546-551. http://dx.doi.org/10.1086/422726.
6. Kumarasamy KK, Toleman MA, Walsh TR, Bagaria J, Butt F, Balakrishnan R, Chaudhary U, Doumith M, Giske CG, Irfan S, Krishnan P, Kumar AV, Maharjan S, Mushtaq S, Noorie T, Paterson DL, Pearson A, Perry C, Pike R, Rao B, Ray U, Sarma JB, Sharma M, Sheridan E, Thirunarayan MA, Turton J, Upadhyay S, Warner M, Welfare W, Livermore DM, Woodford N. 2010. Emergence of a new antibiotic resistance mechanism in India, Pakistan, and the UK: a molecular, biological, and epidemiological study. Lancet Infect Dis 10:597-602. http://dx.doi.org/10.1016/S1473-3099(10)70143-2.
7. Nordmann P, Poirel L, Mak JK, White PA, McIver CJ, Taylor P. 2008. Multidrug-resistant Salmonella strains expressing emerging antibiotic resistance determinants. Clin Infect Dis 46:324-325. http://dx.doi.org/10 .1086/524898.
8. Fischer J, Rodriguez I, Schmoger S, Friese A, Roesler U, Helmuth R, Guerra B. 2012. Salmonella enterica subsp. Enterica producing VIM-1 carbapenemase isolated from livestock farms. J Antimicrob. Chemother 68:478-480. http://dx.doi.org/10.1093/jac/dks393.
9. Savard P, Gopinath R, Zhu W, Kitchel B, Rasheed JK, Tekle T, Roberts A, Ross T, Razeq J, Landrum BM, Wilson LE, Limbago B, Perl TM, Carroll KC. 2011. First NDM-positive Salmonella sp. strain identified in the United States. Antimicrob Agents Chemother 55:5957-5958. http://dx .doi.org/10.1128/AAC.05719-11.
10. Huang J, Wang M, Ding H, Ye M, Hu F, Guo Q, Xu X, Wang M. 2013. New Delhi metallo-lactamase-1 in carbapenem resistant Salmonella strain, China. Emerg Infect Dis 19:2049-2051. http://dx.doi.org/10.3201 /eid1912.130051.
11. Grimont PAD, Weill FX. 2007. Antigenic formulas of the Salmonella serovars. WHO Collaborating Centre for Reference and Research on Salmonella, Institut Pasteur, Paris, France.
12. th informational supplement. CLSI M100-S24. CLSI, Wayne, PA.
13. British Society of Antimicrobial and Chemotherapy. 2012. BSAC methods for antimicrobial susceptibility testing, version 11.1. http://bsac.org .uk/wp-content/uploads/2012/02/Version-11.1-2012-Final-.pdf.
14. Stuart CJ, Leverstein-Van Hall MA. 2010. Guideline for phenotypic screening and confirmation of carbapenemases in Enterobacteriaceae. Int J Antimicrob Agents 36:205-210. http://dx.doi.org/10.1016/j.ijantimicag .2010.05.014.
15. Mushtaq S, Irfan S, Sarma JB, Doumith M, Pike R, Pitout J, Livermore DM, Woodford N. 2011. Phylogenetic diversity of Escherichia coli strains producing NDM-type carbapenemases. J Antimicrob. Chemother 66: 2002-2005. http://dx.doi.org/10.1093/jac/dkr226.
16. Walsh TR, Weeks J, Livermore DM, Toleman MA. 2011. Dissemination of NDM-1 positive bacteria in the New Delhi environment and its implications for human health: an environmental point prevalence study. Lancet Infect Dis 11: 355-362. http://dx.doi.org/10.1016/S1473 -3099(11)70059-7.
17. EUCAST. 2003. The Salm-gene project-a European collaboration for DNA fingerprinting for food-related salmonellosis. http://www.eurosurveillance .org/ViewArticle.aspx?ArticleId-401.